Table 1. Distribution of participants and bladder cancer and UCC cases according to tumour aggressiveness during 11 years of follow-up in the 10 countries participating in the EPIC study.
| Country | All | Person-years | Bladder cancer cases | UCC cases | Aggressive UCC | Non-aggressive UCC |
|---|---|---|---|---|---|---|
| Denmark | 55 016 | 601 466 | 303 | 284 | 112 | 80 |
| France | 67 385 | 699 360 | 31 | 24 | 13 | 6 |
| Germany | 48 583 | 480 614 | 199 | 171 | 46 | 40 |
| Greece | 26 032 | 247 711 | 45 | 25 | 5 | 6 |
| Italy | 44 541 | 500 407 | 183 | 143 | 45 | 42 |
| Norway | 35 169 | 342 279 | 24 | 24 | 8 | 2 |
| Spain | 40 002 | 482 582 | 146 | 138 | 24 | 61 |
| Sweden | 48 684 | 638 931 | 289 | 281 | 90 | 80 |
| The Netherlands | 36 505 | 431 252 | 104 | 101 | 30 | 29 |
| United Kingdom | 75 395 | 838 397 | 251 | 234 | 57 | 67 |
| TOTAL | 477 312 | 5 262 998 | 1575 | 1425 | 430 | 413 |
Abbreviations: EPIC=European Prospective Investigation into Cancer and Nutrition study; UCC=urothelial cell carcinoma.